Medicines For Europe And European Commission Aligned On Energy Rationing
Supply Chain Disruptions Could Affect Biological And Antibiotic Medicines The Most
Executive Summary
Medicines for Europe has urged the European Commission to exempt pharmaceutical suppliers, particularly those of biologic and antibiotic medicines, from any perspective energy rationing in the region, in line with new public guidelines.
You may also be interested in...
2022 Hires Reflect Global Challenges And Opportunities
Executive changes in 2022 reveal how the industry is adjusting to a volatile post-COVID environment.
EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.
EU Drug Supply In Jeopardy Without Energy Support, Warns Medicines For Europe
Medicines for Europe calls for the pharmaceutical industry to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. Inflation and energy costs threaten European drug makers with closures and rationing, says the industry body.